Animal mRNA Vaccine Portfolio

About Areterna

Areterna is a specialized tools and raw materials company powering the next generation of cell and gene therapies, particularly in the mRNA and in vivo CAR-T space. As a subsidiary of China's Synthgene Biotechnology, it leverages its parent company's deep expertise in nucleic acid chemistry, scalable GMP manufacturing, and an AI-assisted discovery platform to debottleneck the supply chain for therapeutic developers. The company is commercial-stage, generating revenue through the sale of its extensive product catalog and contract services, while also developing its own pipeline of low-cost animal mRNA vaccines for out-licensing.

Therapeutic Areas